Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

New jury fails to reach verdict in J&J South Carolina talc cancer trial

Published 11/15/2018, 08:16 PM
Updated 11/15/2018, 08:20 PM
© Reuters. FILE PHOTO:  A bottle of Johnson's Baby Powder is seen in a photo illustration taken in New York

By Tina Bellon

(Reuters) - A second South Carolina jury on Thursday failed to reach a verdict in the retrial of a case by a woman whose family said her long-term use of Johnson & Johnson's (N:JNJ) baby powder led to her death from asbestos-related cancer.

The case of Bertila Boyd-Bostic, who died of a rare form of cancer in 2017 at the age of 30, is the latest in a series of trials in the United States that center around allegations that the company's talc-based powder contains cancer-causing asbestos.

In May, a deadlocked jury at the Darlington County Court of Common Pleas in Charleston failed to reach a verdict in the first trial.

J&J, which denies the allegations, to date has lost two trials and won three in the litigation over whether Johnson's Baby Powder causes mesothelioma, a tissue cancer closely linked to asbestos exposure. Jury trials in another four mesothelioma cases have resulted in mistrials because jurors could not agree on a verdict or because the plaintiff died.

J&J, faced with some 11,700 U.S. talc lawsuits, in a statement on Thursday said it believed the mistrials, as well as the verdicts clearing it of liability reflected the "diligent review" by juries in the cases.

"We look forward to a new trial to present our defense, which rests on decades of independent, non-litigation-driven scientific evaluations, none of which have found that Johnson's Baby Powder contains asbestos," the company said.

Christopher Swett, a lawyer for Boyd-Bostic's family, in a statement said plaintiffs were disappointed with Thursday's result. Swett said the trial court judge had urged the parties to consider a settlement, but that J&J "refuses to be reasonable and take responsibility."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The New Brunswick, New Jersey-based company in the past has said that it was not considering to settle talc cases and currently is appealing all jury verdicts against it.

Of the 11,700 talc lawsuits, more than 9,700 involve claims over ovarian cancer, recent filings in federal court in New Jersey, where most of the cases are consolidated, showed.

The remaining plaintiffs allege asbestos in J&J's talc caused them to develop mesothelioma.

J&J has been fighting talc cancer lawsuits for several years, but the litigation shifted in recent months to include allegations of asbestos contamination.

In July, a Missouri jury hit J&J with a massive $4.69 billion verdict in the first trial alleging asbestos contamination has caused ovarian cancer in 22 women. That decision is under appeal.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.